L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia

• Published in: Experimental Oncology
• Date: 2017
• Main Authors: Skrypnyk, I., Maslova, G., Lymanets, T., Gusachenko, I.
• Format: Article
• Language: English
• Published: Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України 2017
• Subjects: Original contributions
• Online Access: https://nasplib.isofts.kiev.ua/handle/123456789/138547
• Journal Title: Digital Library of Periodicals of National Academy of Sciences of Ukraine
• Cite this: L-arginine is an effective medication for prevention of endothelial dysfunction, a predictor of anthracycline cardiotoxicity in patients with acute leukemia / I. Skrypnyk, G. Maslova, T. Lymanets, I. Gusachenko // Experimental Oncology. — 2017 — Т. 39, № 4. — С. 308–311. — Бібліогр.: 12 назв. — англ.

Aim: To evaluate the effectiveness of L-arginine in the prevention of endothelial dysfunction, which may be a predictor of anthracycline-induced myocardial injury, in patients with acute leukemia (AL) on the background of anthracycline antibiotics low cumulative doses from 100 to 200 mg/m2. Material...